Aurobindo Pharma Ltd
STALWARTLOWHealthcareBSE: 524804NSE: AUROPHARMA
Final Score
79/100
Geometric mean of 5 dimension scores
ClassificationQUANT
POTENTIAL LONG
Overall Rank
#80
Sector Rank
#9
Healthcare
Price-to-Earnings Ratioi
21.9×
▲ vs sector 30.4×
Return on Capital Employedi
14.2%
≈ sector 14%
Return on Equityi
11.1%
▼ vs sector 12.7%
Piotroski F-Scorei
9/9
Market Capitalizationi
₹77.5K Cr
▲ vs sector ₹1.1K Cr
Dividend Yieldi
0.3%
▲ vs sector 0%
Catalysts
No catalysts identified.
Risks
- −The company has delivered a poor sales growth of 6.55% over past five years.
- −Company has a low return on equity of 10.2% over last 3 years.
- −Company might be capitalizing the interest cost
- −Dividend payout has been low at 10.4% of profits over last 3 years